Global lancing devices and equipment Market
Medical Equipment

What’s Driving Growth in the Lancing Devices And Equipment Market? Insights into Key Trends and Opportunities

Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

What is the Anticipated CAGR of the Lancing Devices And Equipment Market, and What Factors Will Drive It?

In recent times, a significant growth has been observed in the market size of lancing devices and equipment. An increase from $3.06 billion in 2024 to $3.35 billion in 2025, reflecting a compound annual growth rate (CAGR) of 9.6%, is expected. Factors such as the growing prevalence of diabetes, convenience for patients, in-home monitoring, and digitization in healthcare are believed to fuel the historical growth period.

In the coming years, the market size for lancing devices and equipment is projected to experience robust growth. It’s projected to increase to $4.78 billion in 2029, with a compound annual growth rate (CAGR) of 9.3%. This growth during the forecast period can be ascribed to the ongoing diabetes outbreak, improvements in testing precision, telehealth and remote monitoring, as well as personalized medicine. Key trends anticipated during the forecast timeframe encompass the incorporation of continuous glucose monitoring (CGM), non-invasive glucose monitoring, user-centered designs, and the use of sustainable and eco-friendly materials.

How Are the key drivers expanding the growth of the Lancing Devices And Equipment Market?

The escalating incidence of diabetes worldwide is propelling the lancing devices and equipment market, given the increasing dependency on these devices for testing blood glucose levels. Lancing devices are essential for diabetics as they enable the collection of blood samples for determining glucose concentrations. According to the IDF Diabetes Atlas, a Belgium-based global resource offering exhaustive data and insights into global diabetes prevalence, care, and treatment, the worldwide incidence of diabetes is expected to rise from 643 million in 2030 to 783 million by 2045, thus leading to an additional 140 million cases. Presently, diabetes is a common health condition among 537 million adults, the majority of who reside in developing nations. It is anticipated that this surge in the diabetic population will bolster the demand for lancing devices and equipment, consequently fueling the growth of the market.

Get Your Free Sample of the Global Lancing Devices And Equipment Market Report Now!

https://www.thebusinessresearchcompany.com/sample.aspx?id=2484&type=smp

Who Are the Top Companies Contributing to the Growth of the Lancing Devices And Equipment Market?

Major companies operating in the lancing devices and equipment market include Abbott laboratories, B. Braun Melsungen AG, Terumo Corporation, F. Hoffmann-La Roche AG, LifeScan Inc., Ascensia Diabetes Care Holdings AG, Becton Dickinson and Company, Bayer AG, Medtronic plc, ARKRAY Inc., Sanofi S.A., Ypsomed Holding AG, Sarstedt AG & Co., Greiner Bio-One, HTL-STREFA S.A, Guangzhou Improve Medical Instruments Co. Ltd., UltiMed Inc., Allison Medical Inc., Artsana S.p.a., Perrigo Diabetes Care, MedExel Co. Ltd., Simple Diagnostics, Stat Medical Inc., Trividia Health, Eli Lilly and Company, Roche Diagnostics, Terumo Corporation, LifeScan, Dynarex Corporation, Dealmed Medical Supplies LLC, Advanced Diabetic Solutions, Medline Industries Inc., Owen Mumford, ARKRAY USA Inc., Nipro Diagnostics Inc., AgaMatrix Inc., Nova Biomedical, Prodigy Diabetes Care LLC, ACON Laboratories Inc.

How Are Market Trends Revolutionizing the Lancing Devices And Equipment Industry in Recent Times?

Manufacturers of lancing devices are progressively integrating personalized vacuum technology into their products to decrease discomfort caused by pricking. These lancing instruments make use of the technology to create a superficial wound on the skin, avoiding deeper pain nerves, and blood is subsequently drawn out via the vacuum. Illustratively, the Genteel Lancing Device is a lancing device that leverages vacuum technology to draw blood from the capillaries and its use is not limited to the fingers; it can be utilized on various parts of the body.

Get Instant Access to the Global Lancing Devices And Equipment Market Report with Swift Delivery!

https://www.thebusinessresearchcompany.com/report/lancing-devices-and-equipment-global-market-report

Which Primary Segments of the Lancing Devices And Equipment Market Are Driving Growth and Industry Transformations?

The lancing devices and equipment market covered in this report is segmented –

1) By Type: Reusable, Disposable

2) By Product: Safety Lancets, Standard Lancets

3) By Penetration Depth: 0.8mm-1mm, 1.1mm- 1.5mm, 1.6mm-2.0mm, Other Penetration Depths

4) By End User: Hospitals and Clinics, Homecare and Home Diagnostics, Diagnostic Centres and Medical Institutions, Research and Academic Laboratories, Other End User

Subsegments:

1) By Reusable: Manual Reusable Lancets, Automated Reusable Lancets

2) By Disposable: Pre-filled Disposable Lancets, Single-use Lancets

What Are the Key Regions Powering Growth in the Lancing Devices And Equipment Market?

North America was the largest region in the global lancing devices and equipment market in 2023. Western Europe was the second-largest region in the lancing devices and equipment market. The regions covered in the lancing devices and equipment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.

What Are the Defining Features of the Lancing Devices And Equipment Market?

Lancing devices and equipment refer to medical tools used to obtain small blood samples, for glucose testing in diabetic patients. These devices consist of a lancet, a small needle or blade, and a mechanism that punctures the skin, usually on the fingertip, to draw blood. Lancing devices feature adjustable depth settings to control penetration and minimize discomfort. They are essential for routine blood glucose monitoring and other diagnostic tests requiring capillary blood samples.

Browse Through More Similar Reports By The Business Research Company:

Drug Delivery Devices Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/drug-delivery-devices-global-market-report

Insulin Drugs Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/insulin-drugs-global-market-report

Smart Insulin Pens Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/smart-insulin-pens-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at [email protected]

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on:

Leave a Reply

Your email address will not be published. Required fields are marked *